News & Trends - Pharmaceuticals

Janssen appoints former Bayer talent as new Senior Manager of Communications & Public Affairs

Health Industry Hub | January 14, 2022 |
[Total: 1    Average: 4/5]

Pharma News: Former Bayer talent has joined Janssen ANZ as Senior Manager, Communications & Public Affairs.

Michelle D’Heureux joins Janssen after four years at Bayer, where she most recently served as the Head of Communications, Health. With deep ties throughout the Australian & New Zealand pharmaceutical sector, Michelle also previously worked in senior communications roles at Novartis, Eli Lilly and Baxter Healthcare.

Janssen ANZ Head of Communications and Public Affairs, Adam Wyldeck said he was thrilled that Michelle was joining his team.

“I am delighted that Michelle has decided to join Janssen. She brings a wealth of experience and knowledge to the company at a time when communications is playing an increasingly critical role for the business.

“Communications and public affairs is changing, the way we interact with our stakeholders is evolving.”

Michelle told Health Industry Hub “Janssen is a highly respected industry leader with a trusted heritage in healthcare.  I’m excited to be part of the team and I look forward to connecting with colleagues across the business to deliver initiatives that drive access and improve patient outcomes.”

You may also like: Novartis, the only pharma company, recognised as a DCA Inclusive Employer

The appointment leads a restructuring of Janssen ANZ’s communications team that will see the appointment of new talent and skills to meet the rapidly changing communications landscape and deliver on the organisation’s ambitious growth outcomes.

Michelle will lead communication activities across multiple therapeutic areas within the Janssen ANZ business, drawing on her considerable experience driving high profile PBS and Pharmac listings and the development of strategic communication plans spanning neuroscience, oncology, ophthalmology and more.

Michelle holds a Bachelor of Arts, Communication Studies from the University of Western Sydney with majors in Public Relations and Health Communication. 

Human Resources

PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals

Health Industry Hub | January 17, 2022 |

Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]


News & Trends - Medical Technology

MedTech News -

Stryker announces fellowships for medtech partner projects

Health Industry Hub | January 17, 2022 |

MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]


News & Trends - Pharmaceuticals

Pharma News - New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

Health Industry Hub | January 17, 2022 |

Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]


News & Trends - Pharmaceuticals

Pharma News -

Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma

Health Industry Hub | January 17, 2022 |

Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]